Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-01-23 @ 4:25 PM
Study NCT ID:
NCT05366166
Status:
RECRUITING
Last Update Posted:
2025-04-23
First Post:
2022-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Olaparib in LA-HNSCC
Sponsor:
Organization: